News of the WeekDRUG SAFETY

Withdrawal of Vioxx Casts a Shadow Over COX-2 Inhibitors

See allHide authors and affiliations

Science  15 Oct 2004:
Vol. 306, Issue 5695, pp. 384-385
DOI: 10.1126/science.306.5695.384

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Will other COX-2 inhibitors suffer a fate similar to that of Vioxx, which was recently found to increase the risk of heart attacks and stroke?